Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Founded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS®) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education and collaboration among disciplines.

ACTRIMS provides an annual Forum for experienced and newer clinicians and researchers to exchange information, debate current issues and discuss advances related to basic research and clinical issues. This CE-accredited meeting stands apart from many traditional medical meetings by offering a singular track of scientific and clinical presentations in an interactive environment

One of the major initiatives of ACTRIMS is to foster the careers of young neurologists in training who have an interest in multiple sclerosis; this is done through a Resident Summit held in conjunction with the annual Forum and a standalone clinical neuroimmunology summit geared towards young scientists.

Mission:
To build a community that advances the science and treatment of MS and related disorders.

Vision:
Improved care and outcomes for individuals with MS and related disorders.

Values:
Community:
ACTRIMS creates a collaborative and inclusive community to advance MS research and care. Their community includes clinicians, researchers, trainees and other organizations interested in advancing MS research and care.

Rigorous Cutting-Edge Science:
ACTRIMS supports transformative basic, translational, and clinical research as well as evidence-based treatment of MS and related diseases.

Developing Young Investigators & Clinicians:
ACTRIMS is committed to engaging young investigators and clinicians through mentorship and education to drive growth and innovation in their field.